You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
AstraZeneca
Harvard Business School

Last Updated: April 7, 2020

DrugPatentWatch Database Preview

Droxidopa - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for droxidopa and what is the scope of patent protection?

Droxidopa is the generic ingredient in one branded drug marketed by Lundbeck Na Ltd and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for droxidopa. One supplier is listed for this compound.

Summary for droxidopa
Recent Clinical Trials for droxidopa

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lundbeck LLCPhase 4
William Ondo, MDPhase 4
St. Joseph's Hospital and Medical Center, PhoenixPhase 2

See all droxidopa clinical trials

Pharmacology for droxidopa
Physiological EffectIncreased Blood Pressure
Medical Subject Heading (MeSH) Categories for droxidopa
Synonyms for droxidopa
(-)-(2S,3R)-2-amino-3-hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid
(-)-(2S,3R)-2-Amino-3-hydroxy-3-(3,4-dihydroxyphenyl)propionic acid
(-)-threo-3-(3,4-Dihydroxyphenyl)-L-serine
(2RS,3RS)-2-AMINO-3-(3,4-DIHYDROXY-PHENYL)-3-HYDROXY-PROPIONIC ACID
(2RS,3RS)-2-AMINO-3-(3,4-DIhydroxyphenyl)-3-HYDROXY-propanoic acid
(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid
(2S,3R)-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic Acid
(2S,3R)-3,4-dihydroxy-phenylserine
(betaR)-beta,3-dihydroxy-L-tyrosine
1-14-00-00685 (Beilstein Handbook Reference)
23651-95-8
23651-95-8,1260173-94-1(HCl)
3,4-Dihydroxyphenylserine
3916-18-5
492-46-6
916A185
AB01566868_01
AKOS015889899
ANW-57465
API0002500
AS-61328
AX8126964
BCP06516
BDBM50103611
beta,3-Dihydroxy-DL-tyrosine threo-
BRN 2852792
CCG-222060
CHEBI:31524
CHEMBL2103827
CS-2468
CTK8B7488
D,L-(3,4-Dihydroxyphenyl)serine
D01277
D4235
DB06262
DL-threo-3-(3,4-Dihydroxyphenyl)serine
DL-threo-3,4-Dihydroxyphenylserine
DL-threo-beta-(3,4-Dihydroxyphenyl)serine
DL-threo-Dihydroxyphenylserine
DL-threo-DOPS
DL-threo-Droxidopa
DL-Tyrosine, beta,3-dihydroxy-, threo-
DL-Tyrosine, beta,3-dihydroxy-, threo- (9CI)
DOPS
Dops (TN)
Droxidopa (JP17/INN)
Droxidopa (L-DOPS,SM-5688)
Droxidopa (L-DOPS)
Droxidopa (L-threo-3-(3,4-Dihydroxyphenyl)serine)
Droxidopa [Latin]
Droxidopa [USAN:INN:JAN]
droxidopa-l-dops
droxidopum
Droxydopa
EINECS 223-480-5
FT-0651749
FT-0667809
GTPL7391
H-DL--(3,4-Dihydroxyphenyl)-DL-Ser-OH
HY-13458
J7A92W69L7
KS-00000ZU4
L-dihydroxyphenylserine
L-DOPS
L-DOPS, >=98% (HPLC)
L-threo DOPS
L-threo-3-(3,4-Dihydroxyphenyl)serine
L-threo-3,4-dihydroxyphenylserine
L-threo-dihydroxyphenylserine
L-threo-DOPS
L-Threodops
L-Tyrosine, beta,3-dihydroxy-, (beta-R)- (9CI)
L-Tyrosine, beta,3-dihydroxy-, (betaR)-
L-Tyrosine, beta,3-dihydroxy-, threo-
LS-145005
MFCD00004266
Norethra
Northera
Northera (TN)
Q-201050
Q907853
QXWYKJLNLSIPIN-JGVFFNPUSA-N
s3041
SCHEMBL134299
Serine, 3-(3,4-dihydroxyphenyl)-, DL-threo-
Serine, 3-(3,4-dihydroxyphenyl)-, L-threo-
SM 5688
SM-5688
SM5688
SR-01000883755
SR-01000883755-1
TC-146210
threo-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic acid
threo-beta,3-Dihydroxy-DL-tyrosine
threo-Dopaserine
Threo-ss,3-dihydroxy-DL-tyrosine
UNII-24A0V01WKS component QXWYKJLNLSIPIN-JGVFFNPUSA-N
UNII-J7A92W69L7
ZINC1482049

US Patents and Regulatory Information for droxidopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-001 Feb 18, 2014 RX Yes No   Start Trial   Start Trial   Start Trial
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-003 Feb 18, 2014 RX Yes Yes   Start Trial   Start Trial   Start Trial
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-002 Feb 18, 2014 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.